{"id": 2181, "input_str": " OTTAWA, ONTARIO --(Marketwired - Nov. 16, 2017 ) - Tetra Bio-Pharma Inc. (\"Tetra\" or the \"Company\") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps(TM), unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. (\"", "correct_token_str": "A", "generated_token_str": "T", "generator_index": 0, "correct_logprobs": [-4.0433855056762695, -1.371251106262207, -0.054446522146463394], "generated_logprobs": [-1.6186206340789795, -7.675839424133301, -10.157493591308594], "generator_names": ["gelu_two_layers/", "gelu_twelve_layers/", "gelu_twenty_four_layers/"]}